Definitive Contract 75F40126C00106
Award Date 8/21/26
Potential Completion Date 2/20/27
Potential Value $350K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the lease of a sensitive long fragment DNA sequencing device. The contract has a potential value of $88,755.00 and a completion date of September 29, 2027. There is no set-aside designation for this award. The original solicitation was a combined synopsis/solicitation posted on May...
- This federal contract award issued by the Food and Drug Administration (FDA) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) is for a project titled "Comprehensive Spatio-Temporal Map of Gene Expression During Lethal Ebola Virus Disease". The $3,246,237.39 definitive contract has a performance period ending on Sep 30, 2023. The contract supports regulatory science and innovation research and development, as described in the FDA's Broad Agency...
- This is a $9,412,272.00 firm fixed price federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to the University of Liverpool in the United Kingdom. The contract is for the characterization of severe coronavirus infection and has a period of performance ending on March 14, 2026. This contract does not have a set-aside designation. The University of Liverpool is a leading research institution known for its expertise in areas such as infectious diseases,...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Eurofins Genomics LLC, a for-profit manufacturer of goods based in Louisville, Kentucky. The contract, a Blanket Purchase Agreement (BPA) call valued at $9,417.60, is for the provision of a SIMPLESEQ 96 REACTIONS, KIT OF 96 product. The contract has a firm fixed price and an ultimate completion date of March...
- This is a Cost Plus Fixed Fee contract awarded by the Food and Drug Administration (FDA) to Public Health England, a UK-based organization, for work related to the "Ebola Virus Disease: Correlates of Protection, Biomarkers of Disease Outcome and Mutations with Implications for Efficacy of Vaccines and Therapeutics" program. The contract has a ceiling value of $3,450,000.00 and a period of performance through March 13, 2021. The contract was awarded on August 28, 2015 and is a...
- The Food and Drug Administration awarded a $87,005 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based sequencing systems. The award, designated as a Total Small Business set-aside and issued on September 13, 2022, calls for the delivery of one long-read sequencing instrument and one automated library preparation instrument to the FDA's facility in New York, NY. The contract has an ultimate completion date...
- This is a $3,490,083 definitive cost contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genomic Labs LTD, a for-profit limited liability company based in the United Kingdom. The contract is for the development of an integrated diagnostic platform that utilizes whole genome sequencing to identify bacterial pathogens and predict antibiotic susceptibility directly from blood samples,...
- Oxford Nanopore Technologies Inc. was awarded a $100,060 firm fixed-price purchase order by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) for a total small business set-aside requirement of two portable long-read whole genome sequencers to support the FDA's epidemiologic investigations and surveillance for foodborne pathogens like Escherichia coli and Clostridium botulinum. The sequencers and associated consumables, support, and installation services are...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Eurofins Genomics LLC, a for-profit manufacturer of goods based in Louisville, Kentucky. The contract, valued at $3,183.20, is for oligonucleotide services and was awarded on a Firm Fixed Price basis under a Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation, indicating open...
- <p>This is a $747,499.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Bugseq Inc., a for-profit foreign-owned company, to provide development and clinical validation from metagenomics data using AI and machine learning techniques. The contract has an ultimate completion date of July 23, 2025 and was awarded on June 21, 2024. The contract does not have a set-aside designation.</p>